ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,975.38
0.55%
US Tech 100
21,012.40
1.30%
다우존스 지수
42,706.56
-0.06%
Bitcoin
102,033.63
3.77%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU
  6. Pharming Group NV (PHARM)

  7. Pharming Group NV (PHARM) 뉴스

PHARM

Pharming Group NV (PHARM)

Pharming Group NV
일자:
정렬 기준:
 검색 관련기사 보기:EU:PHARM
일자시간출처헤드라인심볼기업
2024/12/1603:45GlobeNewswire Inc.Pharming announces public cash offer to the shareholders of Abliva ABEU:PHARMPharming Group NV
2024/12/1115:00GlobeNewswire Inc.Pharming announces positive topline data in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
2024/11/0516:00GlobeNewswire Inc.Pharming Group to participate in November investor conferenceEU:PHARMPharming Group NV
2024/10/2414:00GlobeNewswire Inc.Pharming Group reports third quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/10/1015:00GlobeNewswire Inc.Pharming Group to report third quarter 2024 financial results on October 24EU:PHARMPharming Group NV
2024/10/1014:00GlobeNewswire Inc.Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulationEU:PHARMPharming Group NV
2024/09/2614:00GlobeNewswire Inc.Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)EU:PHARMPharming Group NV
2024/09/0414:00GlobeNewswire Inc.Pharming Group to participate in September investor conferencesEU:PHARMPharming Group NV
2024/08/0114:00GlobeNewswire Inc.Pharming Group reports second quarter and first half 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/07/1815:00GlobeNewswire Inc.Pharming Group to report second quarter and first half 2024 financial results on August 1EU:PHARMPharming Group NV
2024/06/0315:00GlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
2024/06/0315:00GlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
2024/05/3105:44GlobeNewswire Inc.Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European UnionEU:PHARMPharming Group NV
2024/05/2200:30GlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/05/2200:30GlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/05/2015:00GlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
2024/05/2015:00GlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
2024/05/1514:00GlobeNewswire Inc.Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/05/0814:00GlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/05/0814:00GlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/04/2415:00GlobeNewswire Inc.Pharming Group to report first quarter 2024 financial results on May 8EU:PHARMPharming Group NV
2024/04/2414:00GlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
2024/04/2414:00GlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
2024/04/2001:43GlobeNewswire Inc.Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/04/1822:04GlobeNewswire Inc.Pharming Group announces the placement of €100 million convertible bonds due 2029EU:PHARMPharming Group NV
2024/04/1815:00GlobeNewswire Inc.Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/04/0814:00GlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
2024/04/0814:00GlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
2024/04/0415:30GlobeNewswire Inc.Pharming Group announces the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/04/0414:00GlobeNewswire Inc.Pharming Group announces the filing of its 2023 Annual Report and Form 20-FEU:PHARMPharming Group NV
 검색 관련기사 보기:EU:PHARM

최근 히스토리

NYSE
KO
Coca Cola
NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
COIN
DOGEUSD
Dogecoin
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
COIN
ADAUSD
Cardano
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유